How much does chemotherapy for nasopharyngeal carcinoma cost? Will it relapse?

How much does chemotherapy for nasopharyngeal carcinoma cost? Will it recur?

1. The incidence of nasopharyngeal carcinoma is higher in middle-aged men. Experts have found that the cause of the disease is generally related to race, genetics, Epstein-Barr virus infection, diet and environmental chemical carcinogens. At present, through the efforts of experts, the 5-year survival rate of nasopharyngeal carcinoma has risen to 75%. Early detection, early diagnosis and early treatment are the key to treatment.

2. Nasopharyngeal carcinoma is not suitable for surgery due to its special location, and radiotherapy is generally the first choice. However, nasopharyngeal carcinoma is prone to lymph node and blood metastasis, and the mortality rate of distant metastasis accounts for 50% of all nasopharyngeal carcinoma deaths. Using chemotherapy to reduce distant metastasis is also an important treatment method in Western medicine.

Chemotherapy for nasopharyngeal carcinoma includes: in the comprehensive application of radiotherapy and chemotherapy, it is divided into induction chemotherapy before radiotherapy, cyclical radiochemotherapy and adjuvant chemotherapy after radiotherapy. Induction chemotherapy often uses DDP cisplatin 5-FU fluorouracil, which is mainly used for patients with advanced disease, skull destruction, large nasopharyngeal mass, cervical lymph nodes larger than 4 cm, and low cervical lymph nodes; concurrent radiochemotherapy often uses DDP, CTX cyclophosphamide, MTX methotrexate, BLM bleomycin, HU hydroxyurea, etc.; recently, there are also reports of using paclitaxel taxol and gemcitabine to treat nasopharyngeal carcinoma abroad. Adjuvant chemotherapy is mostly carried out about 1 month after the end of radiotherapy, and its medication is basically induction chemotherapy; for patients with distant metastasis who are difficult to cure with chemotherapy alone, palliative chemotherapy can be used to relieve patients' pain and improve their quality of life. The schemes include DDP5-FU, DDP5-FUCF tetrahydrofolate, DDPBLMADM epirubicin, etc.